Inozyme Pharma Inc. (INZY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inozyme Pharma Inc.

    NASDAQ: INZY · Real-Time Price · USD
    4.00
    0.00 (0.00%)
    At close: Jun 30, 2025, 3:59 PM

    Inozyme Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 21.08M 34.59M 32.91M 23.32M
    Short-Term Investments
    		 92.01M 154M 94.95M 88.48M
    Long-Term Investments
    		 n/a n/a 354K 354K
    Other Long-Term Assets
    		 1.16M 2M 3.81M 3.41M
    Receivables
    		 467K 385K 115K 62K
    Inventory
    		 n/a n/a -115K -62K
    Other Current Assets
    		 311K n/a n/a n/a
    Total Current Assets
    		 120.68M 196.25M 131.39M 115.34M
    Property-Plant & Equipment
    		 1.35M 2.59M 3.64M 4.44M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 2.51M 4.6M 7.8M 8.2M
    Total Assets
    		 123.18M 200.85M 139.19M 123.54M
    Account Payables
    		 2.53M 1.17M 2.54M 2.39M
    Deferred Revenue
    		 n/a n/a 3.81M n/a
    Short-Term Debt
    		 15.41M n/a 816K 731K
    Other Current Liabilities
    		 12.29M 8.77M 7.74M 5.4M
    Total Current Liabilities
    		 33.9M 14.69M 14.71M 11.63M
    Long-Term Debt
    		 31.46M 44.77M 4.14M n/a
    Other Long-Term Liabilities
    		 n/a n/a 124K n/a
    Total Long-Term Liabilities
    		 31.46M 45.68M 6.09M 2.64M
    Total Liabilities
    		 65.36M 60.37M 20.8M 14.27M
    Total Debt
    		 46.87M 46.59M 6.78M 3.37M
    Common Stock
    		 6K 6K 4K 2K
    Retained Earnings
    		 -387.95M -285.93M -214.76M -147.7M
    Comprehensive Income
    		 69K 41K -205K 18K
    Shareholders Equity
    		 57.83M 140.48M 118.59M 109.27M
    Total Investments
    		 92.01M 154M 94.95M 88.48M

    Add to Watchlist